<DOC>
	<DOCNO>NCT01330524</DOCNO>
	<brief_summary>In study 16 Patients diagnose Nonarteritic Anterior Ischemic Optic Neuropathy ( NSION ) sudden mono ocular vision loss associate optic disc edema positive Marcus Gunn le 30 day without exclusion criterion randomly divide two group 1 ) control 2 ) case . In case group Avastin Triamcinolone inject trough vitreal placebo inject control group . BCVA Visual field measure two group .</brief_summary>
	<brief_title>Comparison Intravitreal Bevacizumab Triamcinolone With Placebo</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Inclusion criterion : Sudden mono ocular vision loss associate optic disc edema positive Marcus Gunn ( &lt; 30 day ) Exclusion criterion : Any eye disease except NAION ( Nonarteritic Anterior Ischemic Optic Neuropathy ) Neurologic defect Abnormal ESR , CRP , history retina vitreal surgery Severe corneal opacity make retina examination impossible</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>